EP2981255B1 |
14 Sep, 2022
|
Therapeutic Uses Of Empagliflozin
|
Apr, 2034
|
10
| |
EP2981271B1 |
14 Nov, 2018
|
Therapeutic Uses Of Empagliflozin
|
Apr, 2034
|
8
| |
EP2397142B1 |
27 Jul, 2022
|
Use Of Dpp Iv Inhibitors
|
May, 2027
|
5
| |
EP2986304B1 |
12 Jan, 2022
|
Pharmaceutical Composition, Methods For Treating And Uses Thereof
|
Apr, 2034
|
4
| |
EP2285410B1 |
26 Sep, 2018
|
Dpp-Iv Inhibitor Combined With A Further Antidiabetic Agent, Tablets Comprising Such Formulations, Their Use And Process For Their Preparation
|
Apr, 2029
|
4
| |
EP2994125B1 |
01 Aug, 2018
|
Efficacious Treatment Of Nsclc And Predictive Clinical Marker Of The Responsiveness Of A Tumour To A Treatment
|
May, 2034
|
4
| |
EP2299987B1 |
21 Feb, 2018
|
Capsule Pharmaceutical Dosage Form Comprising A Suspension Formulation Of An Indolinone Derivative
|
Jun, 2029
|
4
| |
EP2608792B1 |
11 Oct, 2017
|
Methods Of Administering An Egfr Inhibitor
|
Aug, 2031
|
4
| |
EP2313087B2 |
22 Nov, 2023
|
Pharmaceutical Dosage Form For Immediate Release Of An Indolinone Derivative
|
Jun, 2029
|
3
| |
EP2482812B1 |
11 Jan, 2023
|
Therapeutic Uses Of Pharmaceutical Compositions
|
Oct, 2030
|
3
| |
EP3517539B1 |
14 Dec, 2022
|
Substituted Dimeric Quinazoline Derivative, Its Preparation And Its Use In Pharmaceutical Compositions For The Treatment Of Type I And Ii Diabetes
|
Jul, 2032
|
3
| |
EP2275132B1 |
03 Mar, 2021
|
Multivalent Pcv2 Immunogenic Compositions And Methods Of Producing Them
|
Dec, 2026
|
3
| |
EP3127551B1 |
29 Jul, 2020
|
Use Of A Pcv2 Immunogenic Composition For Lessening Clinical Symptoms In Pigs
|
Dec, 2026
|
3
| |
EP2956483B1 |
27 May, 2020
|
Therapeutic And Diagnostic Target For Cancer Comprising Dll3 Binding Reagents
|
Feb, 2034
|
3
| |
EP2395983B1 |
08 Apr, 2020
|
Pharmaceutical Composition Comprising A Sglt2 Inhibitor, A Dpp-Iv Inhibitor And Optionally A Further Antidiabetic Agent And Uses Thereof
|
Feb, 2030
|
3
| |
EP2460820B8 |
19 Jun, 2019
|
Pcv2 Immunogenic Compositions And Methods Of Producing Such Compositions
|
Dec, 2025
|
3
| |
EP2451445B1 |
03 Apr, 2019
|
Process For Drying Of Bibw2992, Of Its Salts And Of Solid Pharmaceutical Formulations Comprising This Active Ingredient
|
Jul, 2030
|
3
| |
EP1968630B1 |
24 Jan, 2018
|
Multivalent Pcv2 Immunogenic Compositions And Methods Of Producing Such Compositions
|
Dec, 2026
|
3
| |
EP3110449B1 |
28 Jun, 2023
|
Medical Use Of A Dpp-4 Inhibitor
|
NA
|
2
| |
EP3362055B1 |
18 Jan, 2023
|
Sglt-2 Inhibitor For Use In The Treatment Of A Metabolic Myopathy
|
Oct, 2036
|
2
| |
EP2566469B1 |
21 Dec, 2022
|
Combination Therapy
|
May, 2031
|
2
| |
EP3035958B1 |
26 Oct, 2022
|
Porcine Circovirus Type 2 (Pcv2) Subunit Vaccine
|
Aug, 2034
|
2
| |
EP2849754B1 |
14 Sep, 2022
|
A Xanthine Derivative As Dpp-4 Inhibitor For Use In The Treatment Of Sirs And/Or Sepsis
|
May, 2033
|
2
| |
EP2729151B1 |
31 Mar, 2021
|
Pharmaceutical Composition, Methods For Treating And Uses Thereof
|
Jul, 2032
|
2
| |
EP3061454B1 |
10 Mar, 2021
|
Parasiticidal Oral Veterinary Compositions Comprising Systemically-Acting Active Agents, Methods And Uses Thereof
|
Jan, 2033
|
2
| |
EP3320919B1 |
27 May, 2020
|
Multivalent Pcv2 Immunogenic Compositions And Methods Of Producing Such Compositions
|
Dec, 2026
|
2
| |
EP2640371B1 |
08 Jan, 2020
|
Vasoprotective And Cardioprotective Antidiabetic Therapy
|
Nov, 2031
|
2
| |
EP2152341B1 |
11 Dec, 2019
|
Atomizer, And Filter
|
May, 2028
|
2
| |
EP2504002B1 |
09 Oct, 2019
|
Treatment Of Genotyped Diabetic Patients With Dpp-Iv Inhibitors Such As Linagliptin
|
Nov, 2030
|
2
| |
EP2481420B1 |
20 Feb, 2019
|
Single Dose Anti-Pcv2 Pig Vaccine
|
Dec, 2027
|
2
| |
EP2992897B1 |
04 Jul, 2018
|
Immunogenic Compositions Comprising Lawsonia Intercellularis
|
Mar, 2026
|
2
| |
EP3485890B1 |
10 May, 2023
|
Treatment Of Metabolic Disorders In Canine Animals
|
NA
|
1
| |
EP3534939B1 |
22 Feb, 2023
|
Vaccine Against Porcine Parvovirus And Porcine Reproductive And Respiratory Syndrome Virus And Methods Of Production Thereof
|
Nov, 2037
|
1
| |
EP3554536B1 |
26 Oct, 2022
|
Recombinant Hvt Vectors Expressing Multiple Antigens Of Avian Pathogens, And Vaccines Comprising Them
|
Dec, 2037
|
1
| |
EP2785374B2 |
17 Aug, 2022
|
Recombinant Gallid Herpesvirus 3 (Mdv Serotype 2) Vectors Expressing Antigens Of Avian Pathogens And Uses Thereof
|
Nov, 2032
|
1
| |
EP2998315B2 |
03 Nov, 2021
|
Newcastle Disease Virus Vectored Avian Vaccines
|
Apr, 2030
|
1
| |
EP1720663B2 |
15 Sep, 2021
|
Atomiser Comprising Coding Means
|
Feb, 2025
|
1
| |
EP3526229B1 |
28 Apr, 2021
|
Process For Preparing Glucopyranosyl-Substituted Benzyl-Benzene Derivatives
|
Oct, 2037
|
1
| |
EP2819669B1 |
21 Apr, 2021
|
Novel Propellant-Gas-Containing Tiotropium Formulation
|
Feb, 2033
|
1
| |
EP3288561B1 |
31 Mar, 2021
|
Methods And Pharmaceutical Compositions Comprising A Sglt2 Inhibitor For Treating Or Improving Erectile Dysfunction
|
Apr, 2036
|
1
| |
EP3344289B1 |
29 Jan, 2020
|
Pestivirus Vaccines For Congenital Tremors
|
Aug, 2036
|
1
| |
EP3370810B1 |
18 Dec, 2019
|
System With Nebulizer And Container
|
Nov, 2036
|
1
| |
EP2433665B1 |
07 Aug, 2019
|
Inhaler And Sieve For An Inhaler
|
Mar, 2029
|
1
| |
EP2190434B1 |
17 Apr, 2019
|
Purin Derivatives For Use In The Treatment Of Fab-Related Diseases
|
Aug, 2028
|
1
| |
EP2731947B1 |
16 Jan, 2019
|
Substituted Quinazolines, The Preparation Thereof And The Use Thereof In Pharmaceutical Compositions
|
Jul, 2032
|
1
| |
EP2931741B1 |
25 Jul, 2018
|
Porcine Parvovirus 5A, Methods Of Use And Vaccine
|
Jan, 2034
|
1
| |
EP2606142B1 |
28 Feb, 2018
|
Method For Inactivating Proteases By Ph Change In A Liquid Obtained From A Cell Culture
|
Aug, 2031
|
1
| |
EP1940349B1 |
14 Feb, 2018
|
Aerosol Formulation For The Inhalation Of Beta Agonists
|
Oct, 2026
|
1
| |
EP2874653B1 |
27 Dec, 2017
|
Method Of Providing Protective Immunity Against Heterologous Leptospira Strains
|
Jul, 2033
|
1
| |
EP1951227B1 |
12 Apr, 2017
|
Use Of Pde Iii Inhibitors Or Calcium Sensitizers For The Treatment Of Asymptomatic (Occult) Heart Failure
|
Nov, 2026
|
1
| |
EP2460817B1 |
29 Mar, 2017
|
Pcv2 Immunogenic Compositions And Methods Of Producing Such Compositions
|
Dec, 2025
|
1
| |
EP1976558B1 |
15 Mar, 2017
|
Use Of A Pcv2 Immunogenic Composition For Lessening Clinical Symptoms In Pigs
|
Dec, 2026
|
1
| |